Latest posts tagged with #NEJM on Bluesky
Great to see this very important and topical RCT which was conducted by @bhcintervention.bsky.social at @bartsintervention.bsky.social published in #NEJM www.nejm.org/doi/full/10....
Immediate or Deferred Nonculprit-Lesion PCI in MI (iMODERN) Study
@krishnaraj82.bsky.social
This latest phase I study in #NEJM of a first-in-class, ORAL! selective #p53 reactivator looks promising
Biomarkers that we were forced to study in med school are now potentially druggable!
www.nejm.org/doi/full/10....
From Dr. Paul Sax’s NEJM blog (HIV and ID Observations): when the question isn’t “What do the guidelines say?” but “What would you actually do?”
Read the blog here: blogs.nejm.org/hiv-id-obser...
#InfectiousDiseases #NEJM #theMednet
Bad sleep made woman's eyelids so floppy they flipped inside out, got stuck https://arstechni.ca #obstructivesleepapnea #floppyeyelidsyndrome #eyelids #Health #sleep #NEJM #eye
Scimanuscript
🏛️ The 1820s. Two continents. Two journals. Two philosophies.
Both are still publishing, but they emerged from fundamentally different origins: one as an agent of disruption, the other as a pillar of consolidation.
🧵👇
#MedicalHistory #TheLancet #NEJM #Scimanuscript
#NEJM paper recommends changes to improve fairness of screening programs required for late-career doctors. Thomas Gallagher @uwbioethics.bsky.social is a coauthor. @uwmedicine.bsky.social @uwdeptmedicine.bsky.social #aging
DynaMed Revolutionizes Clinical Decision Making with Same-Day NEJM Access #United_States #Ipswich #NEJM #EBSCO #DynaMed
Dans un essai parrainé par #JandJ publié dans le #NEJM, une combinaison d’#immunothérapie expérimentale a permis de maintenir plus de 80 % des patients vivants et sans progression près de trois ans.
Thérapie standard ?
Environ 30 %.
I want to thank my co-authors Hélène Eltchaninoff, Elaine Tseng & Vinod Thourani, who argue pros and cons for this interesting vignette in our latest #NEJM Clinical Decisions. Read the full discussion below and cast your vote. @nejm.org @ai.nejm.org
✨ Recently published: Among adults aged 65–79 in the GALFLU trial (n=103,169), the high-dose inactivated influenza vaccine appeared to be associated with fewer hospitalizations for influenza or PNA compared with the standard dose. #NEJM
www.nejm.org/do/10.1056/N...
New #NEJM report led by Yuxuan Wang
In collaboration with Bert Vogelstein and my lab:
nejm.org/doi/full/10....
➡️ctDNA methylation profiling of blood can identify patients with irAEs
➡️irAEs often involve multiorgan tissue injury
📢 Hot from the Press: Now published in #NEJM!
We are excited to share that the pivotal DESTINY-Breast05 data „Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer“ presented by Sibylle Loibl at #SABCS2025, is now available.
🔗 Read the full NEJM article:
www.nejm.org/doi/full/10....
Wellcome #NejmClinician !
NEJM Clinician — Finding the Medicine That Matters in an Age of Infinite Evidence
www.nejm.org/doi/full/10....
@nejm.org
#CardioSky #nejm
In the SONIA trial, adjunct low-dose glucocorticoid use in patients hospitalized with CAP in a low-resource setting was associated with lower 30-day all-cause mortality compared with standard care. #NEJM
www.nejm.org/doi/full/10....
Among mechanically ventilated patients, selective digestive decontamination did not reduce in-hospital mortality compared with standard care. #NEJM #PITB #SuDDICU
www.nejm.org/doi/full/10....
🚨 New Trial Alert!
Atacicept shows a significant reduction in proteinuria in IgAN at 36 wks.
Fresh from #NEJM and highlighted for #KidneyWeek!
📊🧬🩺nejm.org/doi/full/10.10…
@hswapnil.medsky.social @kidneyboy.bsky.social @brianrifkin.bsky.social @jmteakell.bsky.social @nephroseeker.medsky.social
Finally, my warmest thanks to the CRICS-TriggerSep Scientific Board for their crucial role in designing and conducting this trial.
https://www.nejm.org/doi/full/10.1056/NEJMoa2502136
#EVERDAC #CriticalCare #ESICM2025 #NEJM #ICU #Research #CRICSTriggerSep
PinkOctober – Research Brings Hope: #INSEMA Study #GBG75
📖 Most recent results have been published in #NEJM: www.nejm.org/doi/full/10....
Exciting news: the latest INSEMA data will be presented as an Oral Presentation at the San Antonio Breast Cancer Symposium #SABCS2025 this December.
Our #NEJM Gaza commentary can be found here. Reminder: Some prominent physicians, other healthcare workers, remain imprisoned without charge, under harsh conditions. Gaza itself lies in ruins: its health system barely functions, essential supplies scarce
www.nejm.org/doi/full/10....
Where was Israel's Medical Establishment? Dr Tamari, an NYC Israeli oncologist, dissects some of the angry responses in Israel to our recent #NEJM commentary about Gaza & ends with a harsh indictment of Israel's health establishment
powerful. simple. true.
#MustRead
www.haaretz.com/opinion/2025...
The ground-breaking #NEJM #randomizedTrial suggests that every #surgery patient at substantial #bleeding risk should receive #tranexamicAcid: 24% #RelativeRisk reduction in serious bleeding.
www.nejm.org/doi/full/10....
Dr Booth presenting the #CCTG #CO21 #CHALLENGE trial to the GI tumours group at #ESMO2025 - the study was recently published in #NEJM www.nejm.org/doi/10.1056/...
Finally, the NEJM allows true and factual reporting about the genocide in Gaza to be published. Hopefully, the Zionazi backlash doesn’t suppress the truth further than it has been!
#FreePalestine
#NEJM
Apixaban for Extended Treatment of Provoked Venous Thromboembolism. #NEJM
"Low-intensity therapy with apixaban for 12 months resulted in a lower risk of symptomatic recurrent VTE than placebo, with a low risk of major bleeding."
www.nejm.org/doi/full/10....
🔑 HI-PRO Trial (NEJM): In pts w/ provoked VTE + enduring risk factors, 12 mo of low-dose apixaban ↓ recurrent VTE (1.3% vs 10%) vs placebo, w/ low major bleed risk. www.nejm.org/doi/full/10.... #VTE #Thrombosis #NEJM
Medical Imaging and Pediatric and Adolescent Hematologic Cancer Risk. #nejm
"Our study suggests an association between exposure to radiation from medical imaging and a small but significantly increased risk of hematologic cancer among children and adolescents."
www.nejm.org/doi/full/10....
In adults with obesity, 72-week treatment with orforglipron led to significantly greater reductions in body weight than placebo; the adverse-event profile was consistent with that of other GLP-1 receptor agonists. #NEJM
www.nejm.org/doi/full/10....
Marburg Virus Disease in Rwanda, 2024 — Public Health and Clinical Responses. #NEJM
Open Access
www.nejm.org/doi/full/10....
